CAS 1464151-33-4

Fórmula: C25H20N4O2

InChI: InChI=1S/C25H20N4O2/c26-15-18-1-3-20(4-2-18)23-16-27-24-10-9-22(17-29(23)24)19-5-7-21(8-6-19)25(30)28-11-13-31-14-12-28/h1-10,16-17H,11-14H2

Chave InChI: FWRFPHJSGLYXTD-UHFFFAOYSA-N

SMILES: C1COCCN1C(=O)C2=CC=C(C=C2)C3=CN4C(=NC=C4C5=CC=C(C=C5)C#N)C=C3

ETC-206

CAS: 1464151-33-4

ETC-206 is a selective inhibitor of MNK1 and MNK2 (IC50s: 64 nM and 86 nM).

Fórmula: C₂₅H₂₀N₄O₂

Pureza: 99.72% - 99.79%

Cor e Forma: Solid

Peso molecular: 408.4519

Ref: TM-T15250

ETC-206

CAS: 1464151-33-4

ETC-206

Fórmula: C₂₅H₂₀N₄O₂

Pureza: ≥98%

Peso molecular: 408.45

Ref: 54-BUP09742

ETC-206

CAS: 1464151-33-4

Fórmula: C₂₅H₂₀N₄O₂

Pureza: 97%

Cor e Forma: Solid

Peso molecular: 408.4519

Ref: IN-DA01EOIP

Tinodasertib

CAS: 1464151-33-4

4-(6-(4-(Morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile

Fórmula: C₂₅H₂₀N₄O₂

Pureza: 97%

Peso molecular: 408.45

Ref: IN-DG00801140

Etc-206

CAS: 1464151-33-4

Etc-206 is a novel molecule that has been shown to have both anti-inflammatory and anticancer properties. Etc-206 inhibits the activity of phosphorylase kinase, which is an enzyme that controls the activity of glycogen and glucose metabolism. Etc-206 also reduces glucose uptake by cells and induces insulin resistance in cancer cells. Etc-206 is currently being studied in clinical trials for inflammatory diseases, diabetes, and cancer.

Fórmula: C₂₅H₂₀N₄O₂

Pureza: Min. 95%

Peso molecular: 408.45 g/mol

Ref: 3D-PIC15133